IOG participates in The Evaluation of the Impact of Health and Social Care Research and Development (HSC R&D) Funding in Northern Ireland
As part of an international team assessing the return on investment in health research funding in Northern Ireland, the Institute on Governance helped to develop and deliver a study analyzing the impacts of research funded by Health and Social Care Research and Development (HSC R&D) Northern Ireland (the government funder of health research in the country) and compared it to assessments of return on investment in other countries. The report, published by lead organization RSM McClure Watters, entitled “The Evaluation of the Impact of Health and Social Care Research and Development (HSC R&D) Funding in Northern Ireland,” revealed that for key areas of research, every £1 invested in research and development in Northern Ireland by HSC R&D has generated £4.14 income in the form of further grants or clinical trials.
The report, commissioned by the Department of Health Social Services and Public Safety (DHSSPS), evaluated the benefits to the Health and Social Care system (HSC) and the wider economy of research and development using thePayback Framework as the basis of analysis, and focusing on three health issues as case studies: cancer, diabetes and mental health. Between 1998 and 2011, just over £40 million HSC R&D funding was issued to 108 Principal Investigators to undertake research in the fields of cancer, diabetes and mental health. The total health and social care R&D budget is significantly less in Northern Ireland per capita than the rest of the UK. Even at its peak in 2008 the total HSC R&D budget in Northern Ireland equated to around £7.63 per capita, less than 50% of what is available in England (an estimated £15.12). This study identified additional and follow-on funding for the HSC R&D supported projects totalling over £53 million. This equates to in the region of £4.14 generated for every £1 of HSC R&D funding invested.
This blog is available in English only.